Neuraminidase inhibitor and amantadine

Lancet

Volumn 355, Issue 9222, 2000, Pages 2254-

  Dawson, J ^a  

^a Alliance Pharmaceuticals Limited   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; SIALIDASE; SIALIDASE INHIBITOR;

DEPRESSION; DRUG EFFICACY; DRUG TOLERABILITY; HEADACHE; HUMAN; INFLUENZA; LETTER; PRIORITY JOURNAL; SIDE EFFECT;

EID: 0034709723     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)72755-0     Document Type: Letter

References (5)

1. L Gubareva L Kaiser FG Hayden Influenza virus neuraminidase inhibitors Lancet 355 2000 827 835
2. JS Oxford IS Logan CW Potter In vivo selection of an influenza A2 strain resistant to amantadine Nature 226 1970 82 83
3. H Heider B Adamczyk HW Presber C Schroeder R Feldblum MK Indulen Occurrence of amantadine and rimantadine resistant influenza A virus strains during the 1980 epidemic Acta Virol 25 1981 395 400
4. M Valette JP Allard M Aymard V Millet Susceptibilities to rimantadine of influenza A/H1N1 and A/H3N2 viruses isolated during the epidemics of 1988 to 1989 and 1989 to 1990 Antimicrob Agents Chemother 37 1993 2239 2240
5. VG Vernier JB Harmon JM Stump TE Lynes JP Marvel DH Smith The toxicological and pharmacologic properties of amantadine hydrochloride Toxicol Appl Pharmacol 15 1969 642 665